2015
DOI: 10.1080/03079457.2015.1069259
|View full text |Cite
|
Sign up to set email alerts
|

Immunogenic and protective efficacy of recombinant protein GtxA-N againstGallibacterium anatischallenge in chickens

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1

Citation Types

3
18
1

Year Published

2016
2016
2023
2023

Publication Types

Select...
7
1

Relationship

0
8

Authors

Journals

citations
Cited by 15 publications
(22 citation statements)
references
References 30 publications
3
18
1
Order By: Relevance
“…This vaccine formulation was adopted in study 1 in order to compare the response elicited by immunizing solely with FlfA + GtxA-N against the response elicited when G. anatis OMVs were also added to the vaccine formulation. Given that immunization with both FlfA [18,22] and GtxA-N [23] was previously reported to be effective in providing protection when co-administered with G. anatis OMVs or other adjuvants, and considering the well known adjuvant role exerted by the OMVs [17,20], the lack of protection observed in group 2 can most likely be attributed to the absence of an adjuvant in the vaccine formulation FlfA + GtxA-N.…”
Section: Discussionmentioning
confidence: 99%
See 2 more Smart Citations
“…This vaccine formulation was adopted in study 1 in order to compare the response elicited by immunizing solely with FlfA + GtxA-N against the response elicited when G. anatis OMVs were also added to the vaccine formulation. Given that immunization with both FlfA [18,22] and GtxA-N [23] was previously reported to be effective in providing protection when co-administered with G. anatis OMVs or other adjuvants, and considering the well known adjuvant role exerted by the OMVs [17,20], the lack of protection observed in group 2 can most likely be attributed to the absence of an adjuvant in the vaccine formulation FlfA + GtxA-N.…”
Section: Discussionmentioning
confidence: 99%
“…The immunization regimes presented in study 1 include all possible combinations of G. anatis OMVs and the recombinant proteins FlfA and GtxA-N ( Figure 1). Although several of these immunogen combinations have been previously tested as vaccine candidates [18,[22][23][24][25], a systematic study including all possible combinations of these immunogens and HF-isolated G. anatis OMVs was not reported yet.…”
Section: In Vivo Studiesmentioning
confidence: 99%
See 1 more Smart Citation
“…(2004) performed a study with a detailed experimental design, including sequential killing of birds between 3 and 24 h postinfection, after intraperitoneal or intravenous infection. Intraperitoneal infection was applied by the same research group in other studies, in order to mimic a peritoneal infection due to ascending bacteria from the cloaca via the oviduct, a hypothesis well known from E. coli infections in layers (Bager et al ., 2013; Pedersen et al ., 2015; Pors et al ., 2016). Testing certain deletion mutants, and/or the efficacy of recombinant proteins to be used as vaccine candidates, fibrinous and purulent peritonitis were noticed, similar to previous studies and expected due to the route of infection.…”
Section: Introductionmentioning
confidence: 99%
“…Some of them have been shown to have immunogenic potential against homologous challenge. Among all the recombinant proteins tested, the N terminus of Gallibacterium toxin A (GtxA-N), which is a well-conserved RTX (repeats in toxin) toxin produced by G. anatis that has both hemolytic and leukotoxic activities (17,18), showed the highest antibody titers in the sera of chickens infected with G. anatis (16). GtxA-N is widespread among Gallibacterium strains of different origins (17,19) and therefore represents a promising candidate for the induction of protective immunity.…”
mentioning
confidence: 99%